|
 |
Antipsychotics for Alzheimer's Patients
(Source: NCBI) - In addition to cognitive decline, 30% to 40% of patients with Alzheimer's disease experience psychiatric and behavioral complications, such as hallucinations, delusions, and aggression.
Cholinesterase Inhibitors for Behavioral Disturbances
(Source: NCBI) - Behavioral disturbances are a frequent clinical feature of dementia in Alzheimer's disease. Many AD patients receive treatment with cholinesterase inhibitors (ChEIs). This review examines the evidence for behavioral effects of the four ChEIs that have been approved for the treatment of mild to moderate AD in the U.S.
Antidepressants and Cognition in Alzheimer's Patients
(Source: NCBI) - Approximately 25-40% of patients with Alzheimer's disease develop depression. Antidepressants are typically used to them.
Mild Cognitive Impairment, Alzheimer's Disease and Depression
(Source: NCBI) - Discriminating Alzheimer's disease (AD) and mild cognitive impairment (MCI) from depression is a challenge.
Decoding Alzheimer's
(Source: BusinessWeek) - Alzheimer's is the only major cause of death in the U.S. where the numbers are getting worse, not better. After more than a century of research, scientists are optimistic that they can find an effective treatment for the disease.
|
|